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Clinical Trials
No Interaction Between Statin Metabolism and Efficacy of Clopidogrel
Several of thewidely used statins are primarilymetabolized by the cytochromeP4503A4 isoenzyme (CYP3A4); this enzyme is also necessary for the conversion of
clopidogrel to its active metabolite. The CHARISMA trial randomized over 16,000
subjects to clopidogrel or placebo. This retrospective analysis compared the efficacy of
clopidogrel in patients taking statins that are primarily metabolized by the CYP3A4
enzyme or via different routes. There was no evidence of an interaction between
clopidogrel and the metabolism of statins. Despite theoretical concerns and ex vivo
testing suggesting a potential negative interaction with concomitant use of clopidogrel
and statins metabolized by CYP3A4, there is no evidence of a clinically significant
interaction in this large, placebo-controlled trial. See page 291. See figure.
Heart Failure
EOB Predicts Risk of Sudden Cardiac Death
Exercise oscillatory breathing (EOB), that is rapid variations in the amount ofexpired gases during strenuous activity, is thought to represent an imbalance
between sympathetic and autonomic stimuli for breathing. Guazzi and colleagues
reviewed cardiopulmonary exercise testing (CPET) results from 156 chronic heart
failure (CHF) patients who were then followed for clinical outcomes. Survivors had
significantly higher peak VO2 and lower VE/VCO2 and were less likely to have EOB.
There were no deaths in subjects who did not have EOB, but more than 30% of
subjects with EOB died. This maladaptive breathing pattern appears to be a strong
predictor of the risk for cardiac mortality in patients with CHF. See page 299.
Figure was originally published in Leite JJ, Mansur AJ, de Freitas HFG, et
al. Periodic breathing during incremental exercise predicts mortality in
patients with chronic heart failure evaluated for cardiac transplantation.
J Am Coll Cardiol 2003;41:2175–81.
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Heart Rhythm Disorders
Increased Risk of Intracranial Hemorrhage in Non-Whites
Shen and colleagues studied the risk of intracranial hemorrhage (ICH) in patientswith atrial fibrillation (AF), looking for interactions between race and the risk of
ICH with warfarin. Warfarin was associated with increased ICH risk in all races, but
the magnitude of risk was greater among non-whites. The hazard ratio for ICH with
whites as referent was 4 for Asians, 2 for Hispanics, and 2 for blacks. These results
suggest that non-whites, especially Asians, are at increased risk for ICH when treated
with warfarin. See page 309. See figure.
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Cardiac Imaging
MSCT Characteristics of Vulnerable Plaques
There is growing interest in using multislice computed tomography (MSCT) notonly to measure percent stenosis, but also to characterize the histology of lesions.
Motoyama and colleagues compared culprit lesion characteristics in 38 patients with
acute coronary syndromes (ACS) and 33 with stable angina. Positive remodeling, low
plaque density, and spotty calcification were significantly more frequent in the ACS
lesions. The presence of all 3 characteristics demonstrated a high positive predictive
value for association with ACS lesions, and the absence of all 3 demonstrated a high
negative predictive value. The computed tomography characteristics of plaques, in-
cluding positive vascular remodeling, low plaque density, and spotty calcification may
be the key to identifying vulnerable lesions. See page 319. See figure.
Cardiac Imaging
MCE Predicts Outcomes in MI Survivors
Myocardial contrast echocardiography (MCE) detects contrast microbubbles atthe capillary level within the myocardium; Dwivedi and colleagues hypothe-
sized that MCE may be a useful risk stratifier in the days following a treated ST-
segment elevation myocardial infarction (MI). MCE was performed on 99 subjects,
most of which were treated with thrombolytics, an average of 7 days post-MI. The
multivariable predictors of cardiac death were increased age, mean coronary luminal
diameter stenosis, and areas of decreased signal onMCE.MCEwas the only indepen-
dent risk factor for subsequent MI. See page 327.
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Preclinical Studies
Stent Coated with TGF-1 Stimulates Collateral Formation
Several cytokines, including transforming growth factor (TGF)-1, can theoreti-cally stimulate the formation of new collateral circulation, yet clinical trials with
these compounds have been disappointing. Grundmann and colleagues hypothesized
that by coating a stentwithTGF-1, high and sustained levels couldbeobtainedwhere
it is most likely to be effective. Using a rabbit hindlimb model, stents with either no
coating (bare-metal stents), a polymer-only coating, or a polymer embedded with
TGF-1 were implanted into the external iliac arteries and then the femoral arteries
were occluded. Perfusion measurements 1 week later revealed that collateral conduc-
tance was nearly 2 times higher in the TGF-1 treatment group than in either control
group. After 1 week, there was no evidence of increased in-stent neointima
formation. This novel stent delivery of TGF-1 may improve collateral circu-
lation formation by increasing the duration of exposure at the critical location.
See page 351. See figure.
